List of Excipients in API varenicline tartrate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing varenicline tartrate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | CHANTIX | varenicline tartrate | 0069-0468 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| Pfizer Laboratories Div Pfizer Inc | CHANTIX | varenicline tartrate | 0069-0468 | CELLULOSE, MICROCRYSTALLINE | |
| Pfizer Laboratories Div Pfizer Inc | CHANTIX | varenicline tartrate | 0069-0468 | CROSCARMELLOSE SODIUM | |
| Pfizer Laboratories Div Pfizer Inc | CHANTIX | varenicline tartrate | 0069-0468 | FD&C BLUE NO. 2 | |
| Pfizer Laboratories Div Pfizer Inc | CHANTIX | varenicline tartrate | 0069-0468 | HYPROMELLOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing varenicline tartrate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 | CELLULOSE, MICROCRYSTALLINE |
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 | CROSCARMELLOSE SODIUM |
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 | HYPROMELLOSE 2910 |
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 | MALTODEXTRIN |
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 | POLYETHYLENE GLYCOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for varenicline tartrate
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
varenicline tartrate drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
varenicline tartrate drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: BUTYLATED HYDROXYANISOLE
varenicline tartrate drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | varenicline tartrate | 68462-893 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
varenicline tartrate drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Medley Pharmaceuticals Limited | varenicline tartrate | 42934-104 |
| Carilion Materials Management | varenicline tartrate | 68151-4952 |
| Carilion Materials Management | varenicline tartrate | 68151-4953 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
varenicline tartrate drug variants containing CELLULOSE, MICROCRYSTALLINE
varenicline tartrate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | varenicline tartrate | 31722-678 |
| Leading Pharma LLC | varenicline tartrate | 69315-402 |
| NorthStar RxLLC | varenicline tartrate | 72603-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
varenicline tartrate drug variants containing CROSCARMELLOSE SODIUM
varenicline tartrate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
varenicline tartrate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | varenicline tartrate | 50090-7182 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
varenicline tartrate drug variants containing FD&C BLUE NO. 2
varenicline tartrate drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE RED
varenicline tartrate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | varenicline tartrate | 31722-678 |
| NorthStar RxLLC | varenicline tartrate | 72603-476 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
varenicline tartrate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | varenicline tartrate | 31722-678 |
| A-S Medication Solutions | varenicline tartrate | 50090-7182 |
| American Health Packaging | varenicline tartrate | 60687-648 |
| NorthStar RxLLC | varenicline tartrate | 72603-476 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYPROPYL CELLULOSE
varenicline tartrate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | varenicline tartrate | 49884-155 |
| American Health Packaging | varenicline tartrate | 60687-648 |
| Glenmark Pharmaceuticals Inc USA | varenicline tartrate | 68462-893 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
varenicline tartrate drug variants containing HYPROMELLOSE
varenicline tartrate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 |
| Indoco Remedies Limited | varenicline tartrate | 14445-153 |
| Rebel Distributors Corp | varenicline tartrate | 21695-633 |
| Camber Pharmaceuticals Inc | varenicline tartrate | 31722-678 |
| AvKARE | varenicline tartrate | 42291-927 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
varenicline tartrate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 |
| Indoco Remedies Limited | varenicline tartrate | 14445-153 |
| Camber Pharmaceuticals Inc | varenicline tartrate | 31722-678 |
| AvKARE | varenicline tartrate | 42291-927 |
| Medley Pharmaceuticals Limited | varenicline tartrate | 42934-104 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
varenicline tartrate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | varenicline tartrate | 68151-4952 |
| Carilion Materials Management | varenicline tartrate | 68151-4953 |
| AVALANCHE PHARMACEUTICAL LLC | varenicline tartrate | 82582-485 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
varenicline tartrate drug variants containing MAGNESIUM STEARATE
varenicline tartrate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 |
| Indoco Remedies Limited | varenicline tartrate | 14445-153 |
| Camber Pharmaceuticals Inc | varenicline tartrate | 31722-678 |
| ENDO USA Inc | varenicline tartrate | 49884-155 |
| A-S Medication Solutions | varenicline tartrate | 50090-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
varenicline tartrate drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 |
| Indoco Remedies Limited | varenicline tartrate | 14445-153 |
| Ajanta Pharma USA Inc | varenicline tartrate | 27241-173 |
| Medley Pharmaceuticals Limited | varenicline tartrate | 42934-104 |
| ENDO USA Inc | varenicline tartrate | 49884-155 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing MALTODEXTRIN
Excipient focus: MICROCRYSTALLINE CELLULOSE 302
varenicline tartrate drug variants containing MICROCRYSTALLINE CELLULOSE 302
| Company | Ingredient | NDC |
|---|---|---|
| Leading Pharma LLC | varenicline tartrate | 69315-402 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing MICROCRYSTALLINE CELLULOSE 302
Excipient focus: POLYETHYLENE GLYCOL
varenicline tartrate drug variants containing POLYETHYLENE GLYCOL
varenicline tartrate drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
varenicline tartrate drug variants containing POLYETHYLENE GLYCOL 400
varenicline tartrate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | varenicline tartrate | 0069-0468 |
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 |
| Rebel Distributors Corp | varenicline tartrate | 21695-633 |
| Ajanta Pharma USA Inc | varenicline tartrate | 27241-173 |
| AvKARE | varenicline tartrate | 42291-927 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
varenicline tartrate drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | varenicline tartrate | 68151-4952 |
| Carilion Materials Management | varenicline tartrate | 68151-4953 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: SILICON DIOXIDE
varenicline tartrate drug variants containing SILICON DIOXIDE
varenicline tartrate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 |
| Indoco Remedies Limited | varenicline tartrate | 14445-153 |
| Camber Pharmaceuticals Inc | varenicline tartrate | 31722-678 |
| ENDO USA Inc | varenicline tartrate | 49884-155 |
| A-S Medication Solutions | varenicline tartrate | 50090-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
varenicline tartrate drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | varenicline tartrate | 0904-7413 |
| Indoco Remedies Limited | varenicline tartrate | 14445-153 |
| Camber Pharmaceuticals Inc | varenicline tartrate | 31722-678 |
| ENDO USA Inc | varenicline tartrate | 49884-155 |
| A-S Medication Solutions | varenicline tartrate | 50090-7135 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing STEARIC ACID
Excipient focus: TALC
varenicline tartrate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | varenicline tartrate | 49884-155 |
| A-S Medication Solutions | varenicline tartrate | 50090-7182 |
| American Health Packaging | varenicline tartrate | 60687-648 |
| >Company | >Ingredient | >NDC |
varenicline tartrate drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
varenicline tartrate drug variants containing TITANIUM DIOXIDE
varenicline tartrate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | varenicline tartrate | 21695-633 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
varenicline tartrate drug variants containing TRIACETIN
varenicline tartrate drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
